1
|
Ananeva A, Bakulina O, Dar’in D, Kantin G, Krasavin M. Dicarboxylic Acid Monoesters in β- and δ-Lactam Synthesis. Molecules 2022; 27:molecules27082469. [PMID: 35458663 PMCID: PMC9032910 DOI: 10.3390/molecules27082469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2022] [Revised: 04/03/2022] [Accepted: 04/08/2022] [Indexed: 02/01/2023] Open
Abstract
A N-(2-methoxy-2-oxoethyl)-N-(phenylsulfonyl)glycine monomethyl ester of the respective dicarboxylic acid was involved in a reaction with imines promoted by acetic anhydride at an elevated temperature. Instead of the initially expected δ-lactam products of the Castagnoli–Cushman-type reaction, medicinally important 3-amino-2-azetidinones were obtained as the result of cyclization, involving a methylene group adjacent to an acid moiety. In contrast, replacing alcohol residue with hexafluoroisopropyl in the same substrate made another methylene group (adjacent to the ester moiety) more reactive to furnishing the desired δ-lactam in the Castagnoli–Cushman fashion.
Collapse
Affiliation(s)
- Anna Ananeva
- Institute of Chemistry, Saint Petersburg State University, 26 Universitetskii Prospect, 198504 Peterhof, Russia; (A.A.); (D.D.); (G.K.)
| | - Olga Bakulina
- Institute of Chemistry, Saint Petersburg State University, 26 Universitetskii Prospect, 198504 Peterhof, Russia; (A.A.); (D.D.); (G.K.)
- Correspondence: (O.B.); (M.K.)
| | - Dmitry Dar’in
- Institute of Chemistry, Saint Petersburg State University, 26 Universitetskii Prospect, 198504 Peterhof, Russia; (A.A.); (D.D.); (G.K.)
| | - Grigory Kantin
- Institute of Chemistry, Saint Petersburg State University, 26 Universitetskii Prospect, 198504 Peterhof, Russia; (A.A.); (D.D.); (G.K.)
| | - Mikhail Krasavin
- Institute of Chemistry, Saint Petersburg State University, 26 Universitetskii Prospect, 198504 Peterhof, Russia; (A.A.); (D.D.); (G.K.)
- Institute of Living Systems, Immanuel Kant Baltic Federal University, 236041 Kaliningrad, Russia
- Correspondence: (O.B.); (M.K.)
| |
Collapse
|
5
|
Asahina Y, Wurtz NR, Arakawa K, Carson N, Fujii K, Fukuchi K, Garcia R, Hsu MY, Ishiyama J, Ito B, Kick E, Lupisella J, Matsushima S, Ohata K, Ostrowski J, Saito Y, Tsuda K, Villarreal F, Yamada H, Yamaoka T, Wexler R, Gordon D, Kohno Y. Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure. J Med Chem 2020; 63:9003-9019. [PMID: 32407089 DOI: 10.1021/acs.jmedchem.9b02101] [Citation(s) in RCA: 41] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Formyl peptide receptor 2 (FPR2) agonists can stimulate resolution of inflammation and may have utility for treatment of diseases caused by chronic inflammation, including heart failure. We report the discovery of a potent and selective FPR2 agonist and its evaluation in a mouse heart failure model. A simple linear urea with moderate agonist activity served as the starting point for optimization. Introduction of a pyrrolidinone core accessed a rigid conformation that produced potent FPR2 and FPR1 agonists. Optimization of lactam substituents led to the discovery of the FPR2 selective agonist 13c, BMS-986235/LAR-1219. In cellular assays 13c inhibited neutrophil chemotaxis and stimulated macrophage phagocytosis, key end points to promote resolution of inflammation. Cardiac structure and functional improvements were observed in a mouse heart failure model following treatment with BMS-986235/LAR-1219.
Collapse
Affiliation(s)
- Yoshikazu Asahina
- Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan
| | - Nicholas R Wurtz
- Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States
| | - Kazuto Arakawa
- Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan
| | - Nancy Carson
- Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States
| | - Kiyoshi Fujii
- Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan
| | - Kazunori Fukuchi
- Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan
| | - Ricardo Garcia
- Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States
| | - Mei-Yin Hsu
- Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States
| | - Junichi Ishiyama
- Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan
| | - Bruce Ito
- Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States
| | - Ellen Kick
- Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States
| | - John Lupisella
- Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States
| | - Shingo Matsushima
- Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan
| | - Kohei Ohata
- Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan
| | - Jacek Ostrowski
- Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States
| | - Yoshifumi Saito
- Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan
| | - Kosuke Tsuda
- Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan
| | - Francisco Villarreal
- Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States
| | - Hitomi Yamada
- Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan
| | - Toshikazu Yamaoka
- Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan
| | - Ruth Wexler
- Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States
| | - David Gordon
- Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States
| | - Yasushi Kohno
- Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan
| |
Collapse
|
7
|
Filatov V, Kukushkin M, Kuznetsova J, Skvortsov D, Tafeenko V, Zyk N, Majouga A, Beloglazkina E. Synthesis of 1,3-diaryl-spiro[azetidine-2,3′-indoline]-2′,4-dionesviathe Staudinger reaction:cis- ortrans-diastereoselectivity with different addition modes. RSC Adv 2020; 10:14122-14133. [PMID: 35498462 PMCID: PMC9051608 DOI: 10.1039/d0ra02374d] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2020] [Accepted: 03/30/2020] [Indexed: 01/31/2023] Open
Abstract
A new synthetic approach for realizing biologically relevant bis-aryl spiro[azetidine-2,3′-indoline]-2′,4-diones was developed based on Staudinger ketene–imine cycloaddition through the one-pot reaction of substituted acetic acids and Schiff bases in the presence of oxalyl chloride and an organic base. A series of [azetidine-2,3′-indoline]-2′,4-diones were synthesized using this method. For comparison, the same compounds were obtained using a known technique, where ketene is generated from pre-synthesized acyl chloride. It was shown that the use of oxalyl chloride for ketene generation in the one-pot reaction at room temperature allows for the reversal of the diastereoselectivity of spiro-lactam formation, unlike previously described procedures. Two experimental techniques of the ketene–imine Staudinger reaction allowed different diastereomers of spiro-indolinone-β-lactams to be obtained.![]()
Collapse
Affiliation(s)
- Vadim Filatov
- Moscow State University
- Department of Chemistry
- Moscow 119991
- Russia
| | - Maksim Kukushkin
- Moscow State University
- Department of Chemistry
- Moscow 119991
- Russia
| | | | - Dmitry Skvortsov
- Moscow State University
- Department of Chemistry
- Moscow 119991
- Russia
- Skolkovo Institute of Science and Technology
| | - Viktor Tafeenko
- Moscow State University
- Department of Chemistry
- Moscow 119991
- Russia
| | - Nikolay Zyk
- Moscow State University
- Department of Chemistry
- Moscow 119991
- Russia
| | - Alexander Majouga
- Moscow State University
- Department of Chemistry
- Moscow 119991
- Russia
- National University of Science and Technology “MISiS”
| | | |
Collapse
|
8
|
Mohamadzadeh M, Zarei M, Vessal M. Synthesis, in vitro biological evaluation and in silico molecular docking studies of novel β-lactam-anthraquinone hybrids. Bioorg Chem 2019; 95:103515. [PMID: 31884134 DOI: 10.1016/j.bioorg.2019.103515] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2019] [Revised: 10/20/2019] [Accepted: 12/16/2019] [Indexed: 02/09/2023]
Abstract
Schiff bases from 2-aminoanthraquinone have been prepared by reaction with aldehydes and used to prepare novel β-lactam-anthraquinone hybrids via [2+2] ketene-imine cycloaddition (Staudinger reaction) reaction. In vitro antibacterial studies of all synthesized compound were carried out against three gram-positive strains Staphylococcus aureus (Methicillin-resistant strain), Enterococcus faecium (Vancomycin-resistant strain) and Bacillus subtilis, and two gram-negative strains Escherichia coli and Pseudomonas aeruginosa. These compounds were further evaluated for their in vitro antifungal activity against Candida albicans, Aspergillus niger and Trichophyton mentagrophytes. Hybrid compounds showed moderate to excellent antibacterial and antifungal activities. Surprisingly, among the tested compounds, some of them revealed equal antibacterial and antifungal properties and even better than standards. In addition, results demonstrated that the new hybrids are very promising antibacterial agents against resistant strains. Also molecular docking studies were carried out by Autodoc software. Penicillin-binding protein 2a (PDB ID: 1VQQ) from methicillin-resistant Staphylococcus aureus strain used as a target which good binding interactions were observed.
Collapse
Affiliation(s)
- Masoud Mohamadzadeh
- Department of Biochemistry, Shiraz Branch, Islamic Azad University, Shiraz, Iran
| | - Maaroof Zarei
- Department of Chemistry, Faculty of Sciences, University of Hormozgan, Bandar Abbas 71961, Iran.
| | - Mahmood Vessal
- Department of Biochemistry, Shiraz Branch, Islamic Azad University, Shiraz, Iran
| |
Collapse
|
12
|
Deketelaere S, Van Nguyen T, Stevens CV, D'hooghe M. Synthetic Approaches toward Monocyclic 3-Amino-β-lactams. ChemistryOpen 2017; 6:301-319. [PMID: 28638759 PMCID: PMC5474669 DOI: 10.1002/open.201700051] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2017] [Indexed: 01/17/2023] Open
Abstract
Due to the emerging resistance against classical β-lactam-based antibiotics, a growing number of bacterial infections has become harder to treat. This alarming tendency necessitates continued research on novel antibacterial agents. Many classes of β-lactam antibiotics are characterized by the presence of the 3-aminoazetidin-2-one core, which resembles the natural substrate of the target penicillin-binding proteins. In that respect, this Review summarizes the different synthetic pathways toward this key structure for the development of new antibacterial agents. The most extensively applied methods for 3-amino-β-lactam ring formation are discussed, in addition to a few less common strategies. Moreover, approaches to introduce the 3-amino substituent after ring formation are also covered.
Collapse
Affiliation(s)
- Sari Deketelaere
- SynBioC Research Group, Department of Sustainable Organic Chemistry and Technology, Faculty of Bioscience EngineeringGhent UniversityCoupure Links 6539000GhentBelgium
| | - Tuyen Van Nguyen
- Institute of ChemistryGraduate University of Science and Technology, Vietnam Academy of Science and Technology18-Hoang Quoc Viet, Cau GiayHanoiVietnam
| | - Christian V. Stevens
- SynBioC Research Group, Department of Sustainable Organic Chemistry and Technology, Faculty of Bioscience EngineeringGhent UniversityCoupure Links 6539000GhentBelgium
| | - Matthias D'hooghe
- SynBioC Research Group, Department of Sustainable Organic Chemistry and Technology, Faculty of Bioscience EngineeringGhent UniversityCoupure Links 6539000GhentBelgium
| |
Collapse
|